Sumitoma Pharma US
Christine Schwall-Pecci, PhD, currently serves as the Director of Medical Affairs Strategy for Women's Health at Sumitomo Pharma America, Inc., since April 2025. Prior experience includes roles as Senior Vice President and Medical Director at BGB Group, where expertise in cardiology, oncology, and women's health was developed. In earlier positions, Christine served as Senior Medical Director and Medical Director with a focus on oncology, cardiology, and biosimilars, and began a career in research and academics as a Graduate Research Assistant at the University of Connecticut, where significant contributions to mitochondrial research were made. Education includes a Ph.D. in Biochemistry from the University of Connecticut and a B.S. in Biology from Fordham University.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.